Progress in Medicinal Chemistry, Volume 60 provides a review of eclectic developments in medicinal chemistry. Each chapter is written by an international board of authors who cover topics including Venoms in Drug Discovery, Designing Protacs as a Drugs, Automated synthesis and enabling tools for Medicinal Chemistry, Use of Molecular Docking Computational Tools in Drug Discovery, and An industrial perspective on co-crystals: screening, identification and development of the less utilized solid form in drug discovery and development.
1. 1 Introduction - p. 192 2. 2 History of automation in medicinal chemistry - p. 195 3. 3 The current state of automation and established technologies in medicinal chemistry - p. 219 4. 4 Automation gaps and emerging technologies - p. 242 5. 5 Medicinal chemists vs machines: What the future holds - p. 258 6. References - p. 262 7. Chapter Four: Use of molecular docking computational tools in drug discovery - p. 290 8. Chapter Five: An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development - p. 363 9. Abstract - p. 346 10. 1 Introduction - p. 346 11. 2 What are co-crystals? - p. 347 12. 3 Intellectual property and regulatory perspective on co-crystals - p. 356 13. 4 Generation, characterisation, and development of co-crystals - p. 376 14. 5 Application of co-crystals - p. 411 15. 6 Summary and looking forward - p. 427 16. References - p. 429
Progress in Medicinal Chemistry, Volume 60 provides a review of eclectic developments in medicinal chemistry. Each chapter is written by an international board of authors who cover topics including Venoms in Drug Discovery, Designing Protacs as a Drugs, Automated synthesis and enabling tools for Medicinal Chemistry, Use of Molecular Docking Computational Tools in Drug Discovery, and An industrial perspective on co-crystals: screening, identification and development of the less utilized solid form in drug discovery and development.
1. 1 Introduction - p. 192 2. 2 History of automation in medicinal chemistry - p. 195 3. 3 The current state of automation and established technologies in medicinal chemistry - p. 219 4. 4 Automation gaps and emerging technologies - p. 242 5. 5 Medicinal chemists vs machines: What the future holds - p. 258 6. References - p. 262 7. Chapter Four: Use of molecular docking computational tools in drug discovery - p. 290 8. Chapter Five: An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development - p. 363 9. Abstract - p. 346 10. 1 Introduction - p. 346 11. 2 What are co-crystals? - p. 347 12. 3 Intellectual property and regulatory perspective on co-crystals - p. 356 13. 4 Generation, characterisation, and development of co-crystals - p. 376 14. 5 Application of co-crystals - p. 411 15. 6 Summary and looking forward - p. 427 16. References - p. 429
